BFC Planning’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$641 Buy
+77
New +$725 ﹤0.01% 3253

Other funds holding BCRX

BFC Planning's BCRX Position: Q3 2026 in Review

BFC Planning opened a new position in BioCryst Pharmaceuticals (BCRX) in Q3 2026: 77 shares worth $641. The stake represents ﹤0.01% of the portfolio and ranks #3253 among its holdings.

241 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.

  • BFC Planning held 77 shares of BioCryst Pharmaceuticals worth $641 as of Q3 2026.
  • BioCryst Pharmaceuticals was a new BFC Planning position in Q3 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3253 holding.
  • 241 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.